Table 4.
Aβ status classification results (five-fold mean ± SD) for the impaired group of the test ADNI.
| Biomarker | # Samples | AUC | Accuracy | Sensitivity | Specificity | Precision |
|---|---|---|---|---|---|---|
| Cognitive | 258 | 0.760 ± 0.001 | 0.709 ± 0.000 | 0.632 ± 0.004 | 0.805 ± 0.005 | 0.801 ± 0.003 |
| CSF | 155 | 0.925 ± 0.003 | 0.849 ± 0.013 | 0.873 ± 0.024 | 0.816 ± 0.007 | 0.871 ± 0.004 |
| T1-MRI | 194 | 0.753 ± 0.002 | 0.697 ± 0.004 | 0.737 ± 0.011 | 0.649 ± 0.017 | 0.713 ± 0.008 |
| Diffusion-MRI | 37 | 0.828 ± 0.027 | 0.735 ± 0.048 | 0.760 ± 0.022 | 0.706 ± 0.083 | 0.755 ± 0.059 |
| T1-MRI and risk | 194 | 0.862 ± 0.003 | 0.777 ± 0.024 | 0.792 ± 0.021 | 0.760 ± 0.043 | 0.796 ± 0.030 |